Hulten E[au] - Search Results

Year	Number of Results
1972	1
1973	1
2006	2
2007	1
2009	2
2010	6
2011	6
2012	10
2013	12
2014	20
2015	10
2016	11
2017	11
2018	6
2019	7
2020	6
2021	3
2022	6
2023	2

1

Myocardial computed tomography perfusion.

Branch KR, Haley RD, Bittencourt MS, Patel AR, Hulten E, Blankstein R. Branch KR, et al. Among authors: hulten e. Cardiovasc Diagn Ther. 2017 Oct;7(5):452-462. doi: 10.21037/cdt.2017.06.11. Cardiovasc Diagn Ther. 2017. PMID: 29255689 Free PMC article. Review.

2

Physical activity, the quadrangle of health, and dementia risk.

Klusewitz S, Hulten EA. Klusewitz S, et al. Among authors: hulten ea. Atherosclerosis. 2022 Nov;360:44-46. doi: 10.1016/j.atherosclerosis.2022.09.009. Epub 2022 Oct 4. Atherosclerosis. 2022. PMID: 36244798 No abstract available.

3

FFRCT: Solid PLATFORM or Thin Ice?

Hulten E, Di Carli MF. Hulten E, et al. J Am Coll Cardiol. 2015 Dec 1;66(21):2324-2328. doi: 10.1016/j.jacc.2015.09.065. Epub 2015 Oct 14. J Am Coll Cardiol. 2015. PMID: 26475206 Free article. No abstract available.

4

Thinking outside the box: clinical and economic implications of extracardiac findings on cardiac computed tomography angiography.

Hulten E, Murthy VL. Hulten E, et al. Heart. 2022 Aug 25;108(18):1426-1427. doi: 10.1136/heartjnl-2022-321009. Heart. 2022. PMID: 35636897 No abstract available.

5

Cardiac sarcoidosis-state of the art review.

Hulten E, Aslam S, Osborne M, Abbasi S, Bittencourt MS, Blankstein R. Hulten E, et al. Cardiovasc Diagn Ther. 2016 Feb;6(1):50-63. doi: 10.3978/j.issn.2223-3652.2015.12.13. Cardiovasc Diagn Ther. 2016. PMID: 26885492 Free PMC article. Review.

6

The Essence of STRATEGY Is Choosing What Not to Do.

Hulten E, Blankstein R. Hulten E, et al. Circ Cardiovasc Imaging. 2016 Oct;9(10):e005540. doi: 10.1161/CIRCIMAGING.116.005540. Circ Cardiovasc Imaging. 2016. PMID: 27894071 No abstract available.

7

Coronary revascularization for patients with non-ST elevation myocardial infarction and chronic kidney disease: Better three hours too soon than a minute too late?

Hulten EA, Gallagher RM. Hulten EA, et al. Atherosclerosis. 2022 Mar;344:57-59. doi: 10.1016/j.atherosclerosis.2022.01.017. Epub 2022 Feb 1. Atherosclerosis. 2022. PMID: 35135697 No abstract available.

8

Recent clinical trials support continued emphasis on patient-first over modality-first approaches to initial test selection in patients with stable ischemic heart disease.

Shah NR, Hulten EA, Tandon S, Murthy VL, Dorbala S, Thompson RC. Shah NR, et al. Among authors: hulten ea. J Nucl Cardiol. 2022 Feb 11. doi: 10.1007/s12350-022-02908-7. Online ahead of print. J Nucl Cardiol. 2022. PMID: 35149975 No abstract available.

9

Cardiac Magnetic Resonance Evaluation of Pulmonary Arterial Hypertension: Transforming From Supplementary to Primary Imaging Modality?

Hulten EA, Bradley AJ. Hulten EA, et al. JACC Cardiovasc Imaging. 2021 May;14(5):943-946. doi: 10.1016/j.jcmg.2020.11.022. Epub 2021 Jan 13. JACC Cardiovasc Imaging. 2021. PMID: 33454268 Free PMC article. No abstract available.

10

The Prognostic Value of Late Gadolinium Enhancement in Nonischemic Heart Disease.

Mrsic Z, Mousavi N, Hulten E, Bittencourt MS. Mrsic Z, et al. Among authors: hulten e. Magn Reson Imaging Clin N Am. 2019 Aug;27(3):545-561. doi: 10.1016/j.mric.2019.04.010. Magn Reson Imaging Clin N Am. 2019. PMID: 31279456 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results